Aprepitant is usually prescribed as part of a combination therapy to prevent acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin. It is often used in conjunction with other antiemetic agents like dexamethasone and 5-HT3 antagonists (e.g., ondansetron).
